Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Cosmo to Participate in Upcoming Investor Conferences
This is a paid press release. Contact the press release distributor directly with any inquiries.
Cosmo to Participate in Upcoming Investor Conferences
TMX Newsfile
Wed, February 18, 2026 at 3:01 PM GMT+9 1 min read
In this article:
CMOPF
-2.58%
Dublin, Ireland–(Newsfile Corp. - February 18, 2026) - Cosmo Pharmaceuticals N.V. (“Cosmo”) is pleased to announce its participation in the following upcoming investor conferences:
UBS European Healthcare Conference 2026
London, United Kingdom
4 March 2026
Svetlana Sigalova, Chief Financial Officer, will participate in one-on-one meetings with investors.
Jefferies Biotech Summit 2026
Miami, United States
11 March 2026
Giovanni Di Napoli, Chief Executive Officer, will participate in one-on-one meetings with investors.
TP ICAP Healthcare Conference
Paris, France
7 May 2026
Members of the management team will participate in meetings with investors.
Investors attending any of the above conferences who would like to meet with Cosmo are welcome to contact the Company’s IR team to arrange an appointment via investor.relations@cosmohc.com.
**About Cosmo **
Cosmo is a life sciences company focused on MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). We design, develop, and manufacture advanced solutions that address critical medical needs and raise the standard of care. Our technologies are trusted by leading global pharmaceutical and MedTech companies and reach patients and healthcare providers around the world. Guided by our purpose - Building Health Confidence - our mission is to empower patients, healthcare professionals, and partners by innovating at the intersection of science and technology. Founded in 1997, Cosmo is headquartered in Dublin, Ireland, with offices in San Diego (USA), and in Lainate, Rome, and Catania (Italy). For more information, visit www.cosmohealthconfidence.com.
**For further information, please contact: **
investor.relations@cosmohc.com
Attachments
PDF - English
To view the source version of this press release, please visit
條款 及 私隱政策
Privacy Dashboard
More Info